Press release
United States Endoscopic Retrograde Cholangiopancreatography Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities
Market Size and GrowthEndoscopic Retrograde Cholangiopancreatography Market is expected to reach at a high CAGR during the forecast period (2024-2031).
Key Development:
United States: Recent ERCP Industry Developments
✅ In July 2025, Olympus launched its latest ERCP endoscopes featuring enhanced imaging technology to improve diagnostic accuracy. This advancement aims to provide clinicians with clearer visuals for better patient outcomes.
✅ In June 2025, Boston Scientific introduced the ExaltTM Model D Single-Use Duodenoscope, designed to reduce infection risks associated with traditional reusable scopes. This innovation enhances patient safety and procedural efficiency.
✅ In May 2025, a study revealed that ERCP procedure volumes declined with age, with 37% of practitioners aged 44 or younger performing over 150 procedures annually. This data underscores the importance of continuous training and skill development in the field.
Japan: Recent ERCP Industry Developments
✅ In July 2025, Japan's healthcare sector reported a surge in ERCP procedures, driven by an aging population and increased incidence of biliary and pancreatic diseases. This trend highlights the growing demand for advanced endoscopic interventions.
✅ In June 2025, Japanese researchers developed a 3D-printed ERCP training simulator, enabling medical professionals to practice complex procedures in a controlled environment. This innovation aims to enhance training effectiveness and procedural proficiency.
✅ In May 2025, a collaborative study between Japanese and international medical institutions focused on improving ERCP techniques for patients with surgically altered anatomy. The research aims to refine approaches and expand the applicability of ERCP in diverse clinical scenarios.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/endoscopic-retrograde-cholangiopancreatography-market?sb
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a specialized procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions of the bile ducts, gallbladder, and pancreas. It allows for visualization, biopsy, stone removal, stent placement, and treatment of obstructions or strictures, making it essential in managing pancreaticobiliary disorders.
Recent Mergers and acquisitions:
United States: Recent ERCP Developments
✅ In August 2025, a multicenter randomized controlled trial evaluated the efficacy and safety of ice water irrigation to the papilla in reducing post-ERCP pancreatitis. The study found that cryoprevention with ice water significantly decreases the incidence of this common complication.
✅ In July 2025, a systematic review examined microbial patterns and incidence rates of infections following ERCP procedures. The review highlighted the importance of infection control measures to mitigate post-procedural complications.
✅ In July 2025, a study discussed the effectiveness of cryoprevention techniques in reducing post-ERCP pancreatitis. The study emphasized the need for further research to optimize preventive strategies.
Japan: Recent ERCP Developments
✅ In June 2025, a team successfully treated a patient with bile duct stricture following gallbladder surgery using magnetic compression anastomosis (MCA). This innovative, non-surgical technique offers a promising alternative to traditional ERCP procedures.
Key Players:
=> LGC Limited, Bio-Rad Laboratories, Merck KGaA, College of American Pathologists, Waters Corporation, FAPAS, Phenova Inc, Weqas, Advanced Analytical Solutions, LLC, Trilogy Analytical Laboratory among others.
Growth Forecast Projected:
The Global Endoscopic Retrograde Cholangiopancreatography Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Endoscopic Retrograde Cholangiopancreatography Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=endoscopic-retrograde-cholangiopancreatography-market
Key Segments:
➥ By Product Type: Endotherapy Devices, Imaging Devices, Endoscopes, Energy Devices, Others
➥ By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stenting
➥ By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
Regional Analysis for Endoscopic Retrograde Cholangiopancreatography Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Endoscopic Retrograde Cholangiopancreatography producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Endoscopic Retrograde Cholangiopancreatography revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/research-report/endoscopic-retrograde-cholangiopancreatography-market?sb
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Endoscopic Retrograde Cholangiopancreatography Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities here
News-ID: 4224473 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Phytopathological Disease Diagnostics Market 2025 | Growth Drivers …
Market Size and Growth
Phytopathological Disease Diagnostics Market reached US$ 123 million in 2023 and is expected to reach US$ 188 million by 2031, growing with a CAGR of 6% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In May 2025, Bio-Rad Laboratories, Inc. partnered with Neogen Corporation to enhance their phytopathological disease diagnostics offerings. This collaboration aims to provide farmers with advanced tools for accurate and timely detection…

United States Refractory Multiple Myeloma Market valuation $3.4 billion by 2030 …
"The Global Refractory Multiple Myeloma Market reached USD 2.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 3.4 billion by 2030 and CAGR of 4.7% during the forecast period 2024-2031." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/refractory-multiple-myeloma-market?sp
United States: Recent Industry Developments
✅ In September 2025, Bristol Myers Squibb launched a next-generation CAR-T therapy targeting…

United States Metastatic Colorectal Cancer Market valuation $4.8 billion by 2030 …
"Global Metastatic Colorectal Cancer Market reached US$ 3.4 billion in 2022 and is expected to reach US$ 4.8 billion by 2030 growing with a CAGR of 4.6% during the forecast period 2024-2031." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/metastatic-colorectal-cancer-market?sp
United States: Recent Industry Developments
✅ In September 2025, Amgen announced positive Phase III results for its bispecific antibody therapy targeting KRAS-mutated metastatic…

United States Erdosteine Market 2025 | Growth Drivers, Trends & Market Forecast, …
Market size and Growth
Erdosteine Market is expected to reach at a high CAGR during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In August 2025, a feasibility study initiated in January 2025 by Zhejiang East Asia Pharmaceutical Co., Ltd. began evaluating the effect of a 2-week Erdosteine regimen as an add-on treatment during respiratory exacerbations in children with bronchiectasis. The study aims to assess safety and efficacy in pediatric…
More Releases for ERCP
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction
Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions.
Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging…
EU5 ERCP and PTC Devices Market to Reach USD 1.5 Billion by 2034
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) are essential diagnostic and therapeutic procedures used to treat conditions affecting the biliary and pancreatic ducts, such as gallstones, tumors, strictures, and obstructions. ERCP is a non-surgical procedure that combines endoscopy and fluoroscopy to evaluate the pancreatic and bile ducts, while PTC is used in cases where ERCP is not feasible, allowing direct visualization of the bile ducts via a needle…
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,…
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by …
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy),…
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market
The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ERCP Catheter is…
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a…